Advanced Biomed Inc.(ADVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADVB Advanced Biomed Inc.

Closed 05-01 16:00:00 EDT

5.27

-0.08

-1.50%

盘后6.80

+1.53+29.03%

19:59 EDT

High5.31	Low5.12	Vol960.63K
Open5.24	D1 Closing5.35	Amplitude3.55%
Mkt Cap7.19M	Tradable Cap1.74M	Total Shares1.36M
T/O5.04M	T/O Rate290.38%	Tradable Shares330.83K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADVB","market":"US","secType":"STK","nameCN":"Advanced Biomed Inc.","latestPrice":5.27,"timestamp":1777665600000,"preClose":5.35,"halted":0,"volume":960634,"hourTrading":{"tag":"盘后","latestPrice":6.8,"preClose":5.27,"latestTime":"19:59 EDT","volume":957162,"amount":7453088.9224,"timestamp":1777679996127,"change":1.53,"changeRate":0.290323,"amplitude":0.631822},"delay":0,"changeRate":-0.014953271028037398,"floatShares":330825,"shares":1364536,"eps":4.10904,"marketStatus":"Closed","change":-0.08,"latestTime":"05-01 16:00:00 EDT","open":5.24,"high":5.31,"low":5.12,"amount":5038467.019516201,"amplitude":0.035514,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.10904,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":5,"adr":0,"listingDate":1740373200000,"exchange":"NASDAQ","adjPreClose":5.35,"preHourTrading":{"tag":"盘前","latestPrice":5.44,"preClose":5.35,"latestTime":"07:43 EDT","volume":31,"amount":164.380011,"timestamp":1777635825317,"change":0.09,"changeRate":0.016822,"amplitude":0.063551},"postHourTrading":{"tag":"盘后","latestPrice":6.8,"preClose":5.27,"latestTime":"19:59 EDT","volume":957162,"amount":7453088.9224,"timestamp":1777679996127,"change":1.53,"changeRate":0.290323,"amplitude":0.631822},"volumeRatio":48.930554},"requestUrl":"/m/hq/s/ADVB/","defaultTab":"news","newsList":[{"id":"2632625640","title":"Advanced Biomed Completes AI Acquisition and Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2632625640","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632625640?lang=en_us&edition=fundamental","pubTime":"2026-05-02 06:47","pubTimestamp":1777675624,"startTime":"0","endTime":"0","summary":"The latest update is out from Advanced Biomed Inc. ( ($ADVB) ). On April 2, 2026, Advanced Biomed Inc. agreed to acquire 100% of Acellent Technolog...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-completes-ai-acquisition-and-leadership-transition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-completes-ai-acquisition-and-leadership-transition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADVB","AIPO","CHAT","ARTY","BK4198","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632354628","title":"Advanced Biomed issues 270,000 unregistered shares valued at $1.08 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632354628","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632354628?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:16","pubTimestamp":1777670173,"startTime":"0","endTime":"0","summary":"Advanced Biomed completed an unregistered issuance of 270,000 common shares on April 30, 2026.Shares were issued to Xiaomin Chen in exchange for 100% equity interest in Acellent Technologies .Consideration was valued at USD 1.08 million, based on USD 4 per share.Issuance relied on Securities Act exemption under Section 4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL9QbhsZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627422605","title":"Advanced Biomed Secures New Short-Term Unsecured Loan Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627422605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627422605?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:17","pubTimestamp":1776201443,"startTime":"0","endTime":"0","summary":"An update from Advanced Biomed Inc. ( ($ADVB) ) is now available. On April 13, 2026, Advanced Biomed Inc. entered into a loan agreement with lender...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-secures-new-short-term-unsecured-loan-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-secures-new-short-term-unsecured-loan-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627424893","title":"Advanced Biomed enters US$600,000 10% unsecured loan with Jie Wang","url":"https://stock-news.laohu8.com/highlight/detail?id=2627424893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627424893?lang=en_us&edition=fundamental","pubTime":"2026-04-15 04:32","pubTimestamp":1776198766,"startTime":"0","endTime":"0","summary":"Advanced Biomed entered a loan agreement April 13, 2026 for USD 600,000 from lender Jie Wang.Financing carries 10% annual interest, accruing from disbursement.Loan matures in six months, with option to extend for an additional six months by mutual written agreement.Company must repay principal plus accrued interest by maturity, with prepayment allowed without penalty.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 14, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL6n1s4B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626235529","title":"Why Advanced Biomed Shares Are Cooling Off Wednesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2626235529","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626235529?lang=en_us&edition=fundamental","pubTime":"2026-04-08 23:53","pubTimestamp":1775663580,"startTime":"0","endTime":"0","summary":"Shares of Advanced Biomed are trading lower Wednesday. Learn why the stock is pulling back after the Acellent Technologies deal.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/08/Highly-Detailed-Close-Up-Concept-Of-Fina_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/08/Highly-Detailed-Close-Up-Concept-Of-Fina_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/04/51710100/why-advanced-biomed-shares-are-cooling-off-wednesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/04/51710100/why-advanced-biomed-shares-are-cooling-off-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4217","SMA","ADVB","BK4150","BK4198","RSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625937810","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2625937810","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625937810?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:26","pubTimestamp":1775561197,"startTime":"0","endTime":"0","summary":"Advanced Biomed  shares were 87% higher pre-bell Tuesday following a 2.9% loss in the previous session.Mawson Infrastructure Group  stock was up 20% after the company said late Monday it signed a cooperation agreement with The Endeavor Investor Group to reconstitute its board.Humana  shares were 9% higher after the Centers for Medicare & Medicaid Services announced a larger-than-expected increase to Medicare Advantage payments for 2027.CVS Health  stock was up 7% following a muted session.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014021.USD","BK4533","BK4600","LU1983260115.SGD","LU1699723380.USD","CVS.AU","BK4023","BK7500","LU0006061336.USD","BK4588","LU0348723411.USD","BK4504","LU0390134368.USD","SG9999014005.SGD","LU0162691827.USD","LU1059921491.USD","LU0070302665.USD","LU0266013472.USD","MIGI","LU1571399168.USD","BK4581","IE00BZ1G4Q59.USD","LU0072461881.USD","BK4595","BK4550","LU0170899867.USD","LU0211331839.USD","HUM","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU1093756168.USD","LU0238689110.USD","IE00BKVL7J92.USD","BK4585","BK4154","BK4196","IE00BSNM7G36.USD","ADVB","LU0320765489.SGD","BK4198","LU1983299246.USD","BK7093","LU0061475181.USD","HUM.AU","LU0432979614.USD","SG9999014013.SGD","LU1093756325.SGD","CVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624662833","title":"Advanced Biomed agrees to buy Acellent Technologies in $1.1 million stock deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2624662833","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624662833?lang=en_us&edition=fundamental","pubTime":"2026-04-04 05:15","pubTimestamp":1775250957,"startTime":"0","endTime":"0","summary":"Advanced Biomed entered a share purchase agreement on April 2, 2026 to acquire 100% of Acellent Technologies .Consideration set at 270,000 Advanced Biomed common shares, valued at about $1.1 million based on $4 per share.Acellent provides AI-powered financial verification and audit solutions.Closing remains subject to completion of financial and legal due diligence.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL53dkFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623320306","title":"Advanced Biomed Announces Leadership Changes and Board Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2623320306","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623320306?lang=en_us&edition=fundamental","pubTime":"2026-03-31 07:32","pubTimestamp":1774913530,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. ( ($ADVB) ) has issued an announcement. Advanced Biomed Inc. reported that on March 25, 2026, Steven I-Fang Cheng resigned fro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-announces-leadership-changes-and-board-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/advanced-biomed-announces-leadership-changes-and-board-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623324630","title":"Advanced Biomed CTO Steven Cheng resigns from board, role","url":"https://stock-news.laohu8.com/highlight/detail?id=2623324630","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623324630?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:36","pubTimestamp":1774906594,"startTime":"0","endTime":"0","summary":"Advanced Biomed reported resignation of Steven I-Fang Cheng as board director, effective March 25, 2026.Yin currently serves as Advanced Biomed chief financial officer.Cheng’s departure was not tied to any dispute over company operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL7bbpDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620491976","title":"Advanced Biomed completes reverse stock split on Feb. 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620491976","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620491976?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:34","pubTimestamp":1773693263,"startTime":"0","endTime":"0","summary":"Advanced Biomed completed a reverse stock split on Feb. 20, 2026, as part of its plan to regain compliance with Nasdaq’s $1 minimum bid price rule. The Nasdaq hearings panel said on March 12, 2026 that the company had maintained a closing bid price of at least $1 per share following the reverse split. The decision allows the stock to remain listed on Nasdaq, subject to a one-year monitoring period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 16, 2026, and is solely responsible for the information contained there","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL4l80lY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616598255","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2616598255","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616598255?lang=en_us&edition=fundamental","pubTime":"2026-03-04 22:34","pubTimestamp":1772634860,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:34 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nAQN2LOPHH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614071405","title":"Advanced Biomed Inc. Announces 1-for-20 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2614071405","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614071405?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:46","pubTimestamp":1772142365,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. said it will carry out a 1-for-20 reverse stock split of its common shares, effective at the open of Nasdaq trading on Feb. 20, 2026. The company said the move is intended to help regain compliance with Nasdaq’s $1.00 minimum bid price rule, and shares will continue trading under the symbol ADVB with a new CUSIP number, 00752P203.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDLbpKKhz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614745307","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:59 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2614745307","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614745307?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:59","pubTimestamp":1771948756,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:59 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nAQN2LNK8X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612320052","title":"Advanced Biomed Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2612320052","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612320052?lang=en_us&edition=fundamental","pubTime":"2026-02-20 08:50","pubTimestamp":1771548634,"startTime":"0","endTime":"0","summary":"19:50 EST Advanced Biomed (ADVB) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/advanced-biomed-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/advanced-biomed-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612482624","title":"BRIEF-Advanced Biomed Inc. Announces 1 For 20 Share Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=2612482624","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612482624?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:11","pubTimestamp":1771416671,"startTime":"0","endTime":"0","summary":"BRIEF-Advanced Biomed Inc. Announces 1 For 20 Share ConsolidationFeb 18 (Reuters) - Advanced Biomed Inc ADVB.O:ADVANCED BIOMED INC. ANNOUNCES 1 FOR 20 SHARE CONSOLIDATIONSource text: ID:nGNXb7jr1PFurther company coverage: ADVB.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZE0BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612448368","title":"Advanced Biomed Announces 1-for-20 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2612448368","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612448368?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:00","pubTimestamp":1771416030,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. said it will implement a 1-for-20 reverse stock split effective at the open of Nasdaq trading on Feb. 20, 2026. The shares will continue to trade under the symbol ADVB with a new CUSIP number, and the company said the move is intended to help it regain compliance with Nasdaq’s $1.00 minimum bid price requirement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via GlobeNewswire  on February 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL7qNznr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4585","ADVB","LU2210149790.SGD","SG9999014005.SGD","BK4198","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4588","LU0314104364.USD","LU2095319765.USD","NDAQ","SG9999014039.USD","BK4112","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611199358","title":"Advanced Biomed Q2 EPS $0.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2611199358","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611199358?lang=en_us&edition=fundamental","pubTime":"2026-02-14 06:59","pubTimestamp":1771023572,"startTime":"0","endTime":"0","summary":"Advanced Biomed (NASDAQ:ADVB) reported quarterly earnings of $0.32 per share.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50630561/advanced-biomed-q2-eps-0-32","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Advanced Biomed Q2 EPS $0.32","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611193465","title":"Advanced Biomed reports HY other income, net of USD 0.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2611193465","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611193465?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:33","pubTimestamp":1771018435,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. released its financial results for the half-year period ended December 31, 2025. The company reported other income, net of USD 0.2 million for the six-month period, compared to an other expense, net of USD 0.07 million for the same period in the previous year. The increase in other income was primarily attributable to an exchange gain resulting from the revaluation of foreign currency balances. During the reporting period, Advanced Biomed Inc. completed the sale of 100 percent of the issued and outstanding shares of its wholly owned subsidiary, Advanced Biomed  Limited, a Hong Kong company. As a result, the subsidiary was deconsolidated from the company's financial statements as of December 31, 2025. Additionally, the company made capital contributions to Advanced Biomed Taiwan to support research and development activities, including a contribution of USD 0.5 million in March 2025. No dividends or other distributions were made to stockholders during the period. Th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL31Y0fs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVB","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611152420","title":"Advanced Biomed Inc. and Chi-Mei Medical Center Launch Clinical Collaboration to Validate A+PerfusC Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2611152420","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611152420?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:00","pubTimestamp":1770987636,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. has announced a clinical research collaboration with Chi-Mei Medical Center to conduct a 120-case feasibility study evaluating the predictive accuracy of the A+PerfusC integrated perfusion 3D cell culture platform. The study will assess how well drug sensitivity results from the A+PerfusC platform, derived from circulating tumor cells obtained via liquid biopsy, correlate with actual patient outcomes. Both parties will share rights to project-related intellectual property and research outcomes, with interim data expected in mid-2026 and full results targeted by year-end. The collaboration aims to advance precision oncology by providing functional, patient-specific drug response data to guide therapy selection.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL6LG1FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","SG9999014013.SGD","NDAQ","BK4198","SG9999014021.USD","LU0314104364.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD","BK4588","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","ADVB","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610067503","title":"Advanced Biomed Inc. Issues Amendment to June 2025 SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2610067503","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610067503?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:01","pubTimestamp":1770757281,"startTime":"0","endTime":"0","summary":"Advanced Biomed Inc. has filed an amendment to its previously issued Form 8-K report with the U.S. Securities and Exchange Commission. The amendment, dated February 10, 2026, serves to supplement and clarify disclosures made in the original filing from June 6, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDLbRCBYm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ADVB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.advanbiomed.com","stockEarnings":[{"period":"1week","weight":-0.1731},{"period":"1month","weight":0.1732},{"period":"3month","weight":-0.1139},{"period":"6month","weight":-0.4434},{"period":"1year","weight":-0.8607},{"period":"ytd","weight":-0.0833}],"compareEarnings":[{"period":"1week","weight":0.0144},{"period":"1month","weight":0.1051},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0537},{"period":"1year","weight":0.296},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Advanced Biomed Inc.","nameEN":"Advanced Biomed Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Advanced Biomed Inc.(ADVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Advanced Biomed Inc.(ADVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Advanced Biomed Inc.,ADVB,Advanced Biomed Inc.股票,Advanced Biomed Inc.股票老虎,Advanced Biomed Inc.股票老虎国际,Advanced Biomed Inc.行情,Advanced Biomed Inc.股票行情,Advanced Biomed Inc.股价,Advanced Biomed Inc.股市,Advanced Biomed Inc.股票价格,Advanced Biomed Inc.股票交易,Advanced Biomed Inc.股票购买,Advanced Biomed Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Advanced Biomed Inc.(ADVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Advanced Biomed Inc.(ADVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}